1. Apoptosis
  2. RIP kinase
  3. Necrostatin 2 racemate

Necrostatin 2 racemate  (Synonyms: Necrostatin 1S; Nec-1S; 7-Cl-O-Nec1)

Cat. No.: HY-14622A Purity: 99.57%
Handling Instructions Technical Support

Necrostatin 2 racemate (Nec-1S), the Necrostatin-1 (HY-15760) stable, is a potent and specific RIPK1 inhibitor lacking the IDO-targeting effect.

연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.

CAS No. : 852391-15-2

사이즈 가격 재고 수량
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO
ready for reconstitution
해외재고보유
Solution
10 mM * 1 mL in DMSO 해외재고보유
Solid
1 mg 해외재고보유
5 mg 해외재고보유
10 mg 해외재고보유
25 mg 해외재고보유
50 mg 해외재고보유
100 mg 해외재고보유
200 mg   견적 받기  
500 mg   견적 받기  

* 장바구니에 담기 전 물품의 수량을 선택해 주십시오.

This product is a controlled substance and not for sale in your territory.

고객리뷰

Based on 30 publication(s) in Google Scholar

Other Forms of Necrostatin 2 racemate:

Top Publications Citing Use of Products

30 Publications Citing Use of MCE Necrostatin 2 racemate

Cell Proliferation/Viability Assay
In Vivo Efficacy Study
WB
IP

    Necrostatin 2 racemate purchased from MedChemExpress. Usage Cited in: J Exp Med. 2026 Jan 5;223(1):e20250603.  [Abstract]

    Primary hepatocytes from Adkf/f or Adkf/f; Alb-Cre mice were treated with CHX (1 μM)/ TNFα (10 ng/ml) for 12 h in the presence or absence of Nec-1s (10 μM).

    Necrostatin 2 racemate purchased from MedChemExpress. Usage Cited in: J Exp Med. 2026 Jan 5;223(1):e20250603.  [Abstract]

    HEK293T cells were transfected with expression vectors for Flag-RIPK1 WT or Flag-RIPK1-R606K in the presence or absence of Nec-1s (10 μM), respectively. The autophosphorylation of RIPK1 was determined with immunoblotting.

    Necrostatin 2 racemate purchased from MedChemExpress. Usage Cited in: Nat Commun. 2024 Oct 2;15(1):8540.  [Abstract]

    Necrostatin 2 racemate (Nec-1s; 20 µM; 500 h). Time-course confluence of PANC-1 or BxPC3 cells treated with GEM and supplemented with Nec-1s, Fer-1 or ZVAD.

    Necrostatin 2 racemate purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2024 Jun 25:e2309021.  [Abstract]

    Time-activity curves of baseline and self-blocking (pretreatment with unlabeled Nec-1s 1.0 and 3.0 mg/kg, i.v.).

    Necrostatin 2 racemate purchased from MedChemExpress. Usage Cited in: Redox Biol. 2024 Aug 10:76:103304.  [Abstract]

    Cell viability in T-47D and MCF-7 cells lines treated with 1.5 μM Abemaciclib in the absence or presence of 2 μM Necrostatin-1s for 24 h.

    View All RIP kinase Isoform Specific Products:

    • Biological Activity

    • 순도&문서

    • References

    • 고객리뷰

    제품 설명

    Necrostatin 2 racemate (Nec-1S), the Necrostatin-1 (HY-15760) stable, is a potent and specific RIPK1 inhibitor lacking the IDO-targeting effect[1].

    IC50 & Target[1]

    RIPK1

     

    Cellular Effect
    Cell Line Type Value Description References
    Jurkat EC50
    0.21 μM
    Compound: 66
    Effective concentration required for inhibition of necroptosis in FADD deficient Jurkat T cells treated with TNF-alpha
    Effective concentration required for inhibition of necroptosis in FADD deficient Jurkat T cells treated with TNF-alpha
    [PMID: 16153840]
    Jurkat IC50
    206 nM
    Compound: 4, 7-cl-O-Nec-1
    Inhibition of death receptor signaling mediated necroptotic cell death in human Jurkat cell deficient in FADD assessed as cell viability after 30 hrs by ATP based viability assay in presence of TNFalpha
    Inhibition of death receptor signaling mediated necroptotic cell death in human Jurkat cell deficient in FADD assessed as cell viability after 30 hrs by ATP based viability assay in presence of TNFalpha
    [PMID: 16408008]
    In Vitro

    Necrostatin 2 racemate (Nec-1S) (1-100 μM; 1 h) potently inhibits RIPK1 autophosphorylation in a dose-dependent manner[1].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    In Vivo

    Necrostatin 2 racemate (Nec-1S) (6 mg/kg; i.v.; once) protects against TNF-induced systemic inflammatory response syndrome (SIRS) without sensitization effect[1].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Animal Model: Female C57BL/6J WT mice, SIRS model[1]
    Dosage: 0.6 mg/kg or 6 mg/kg
    Administration: Intravenous injection, once
    Result: Showed protective effect at 6 mg/kg.
    분자량

    277.71

    화학식

    C13H12ClN3O2

    CAS No.
    Appearance

    Solid

    Color

    White to light yellow

    SMILES

    ClC1=C2C(C(CC3C(N(C)C(N3)=O)=O)=CN2)=CC=C1

    선적

    Room temperature in continental US; may vary elsewhere.

    보관
    Powder -20°C 3 years
    4°C 2 years
    In solvent -80°C 1 year
    -20°C 6 months
    용액&용해도
    In Vitro: 

    DMSO : ≥ 50 mg/mL (180.04 mM; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

    *"≥" means soluble, but saturation unknown.

    Preparing
    Stock Solutions
    Concentration Solvent Mass 1 mg 5 mg 10 mg
    1 mM 3.6009 mL 18.0044 mL 36.0088 mL
    5 mM 0.7202 mL 3.6009 mL 7.2018 mL
    View the Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 1 year; -20°C, 6 months. When stored at -80°C, please use it within 1 year. When stored at -20°C, please use it within 6 months.

    • 몰농도 계산기

    • 농도 희석 계산기

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass
    =
    Concentration
    ×
    Volume
    ×
    Molecular Weight *

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    This equation is commonly abbreviated as: C1V1 = C2V2

    Concentration (start)

    C1

    ×
    Volume (start)

    V1

    =
    Concentration (final)

    C2

    ×
    Volume (final)

    V2

    In Vivo:

    Select the appropriate dissolution method based on your experimental animal and administration route.

    For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
    To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
    The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

    • Protocol 1

      Add each solvent one by one:  10% DMSO    40% PEG300    5% Tween-80    45% Saline

      Solubility: ≥ 3 mg/mL (10.80 mM); Clear solution

      This protocol yields a clear solution of ≥ 3 mg/mL (saturation unknown).

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (30.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

      Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
    • Protocol 2

      Add each solvent one by one:  10% DMSO    90% (20% SBE-β-CD in Saline)

      Solubility: ≥ 3 mg/mL (10.80 mM); Clear solution

      This protocol yields a clear solution of ≥ 3 mg/mL (saturation unknown).

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (30.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.

      Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
    In Vivo Dissolution Calculator
    Please enter the basic information of animal experiments:

    Dosage

    mg/kg

    Animal weight
    (per animal)

    g

    Dosing volume
    (per animal)

    μL

    Number of animals

    Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
    Please enter your animal formula composition:
    %
    DMSO +
    +
    %
    Tween-80 +
    %
    Saline
    Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
    The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
    Calculation results:
    Working solution concentration: mg/mL
    Method for preparing stock solution: mg drug dissolved in μL  DMSO (Stock solution concentration: mg/mL).
    The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).
    Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.
     If the continuous dosing period exceeds half a month, please choose this protocol carefully.
    Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
    순도&문서

    Purity: 99.57%

    References

    Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 1 year; -20°C, 6 months. When stored at -80°C, please use it within 1 year. When stored at -20°C, please use it within 6 months.

    Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
    DMSO 1 mM 3.6009 mL 18.0044 mL 36.0088 mL 90.0220 mL
    5 mM 0.7202 mL 3.6009 mL 7.2018 mL 18.0044 mL
    10 mM 0.3601 mL 1.8004 mL 3.6009 mL 9.0022 mL
    15 mM 0.2401 mL 1.2003 mL 2.4006 mL 6.0015 mL
    20 mM 0.1800 mL 0.9002 mL 1.8004 mL 4.5011 mL
    25 mM 0.1440 mL 0.7202 mL 1.4404 mL 3.6009 mL
    30 mM 0.1200 mL 0.6001 mL 1.2003 mL 3.0007 mL
    40 mM 0.0900 mL 0.4501 mL 0.9002 mL 2.2505 mL
    50 mM 0.0720 mL 0.3601 mL 0.7202 mL 1.8004 mL
    60 mM 0.0600 mL 0.3001 mL 0.6001 mL 1.5004 mL
    80 mM 0.0450 mL 0.2251 mL 0.4501 mL 1.1253 mL
    100 mM 0.0360 mL 0.1800 mL 0.3601 mL 0.9002 mL
    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.
    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    최근 본 상품:

    온라인 문의

    Your information is safe with us. * Required Fields.

    상품명

     

    Requested Quantity *

    고객명 *

     

    호칭

    메일주소 *

     

    전화번호 *

    Department

     

    회사명 *

    City

    Country or Region *

         

    비고

    대량구매 문의

    Inquiry Information

    상품명:
    Necrostatin 2 racemate
    Cat. No.:
    HY-14622A
    수량:
    MCE Japan Authorized Agent: